|
End-of-day quote
Korea S.E.
23/09/2026
|
5-day change | 1st Jan Change | ||
| 8,180.00 KRW | +12.21% |
|
+21.55% | +19.94% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +12.21% | +21.55% | +51.76% | +82.18% | +19.94% | +0.99% | - | - | - | 142M | |
| +4.61% | +11.60% | +24.74% | +57.25% | +78.44% | +149.40% | +792.16% | +246.08% | +3,760.15% | 56.33B | |
| +1.63% | -4.27% | -8.96% | +16.51% | +23.15% | +10.60% | +50.60% | +4.24% | +124.87% | 24.65B | |
| -0.90% | -4.38% | -12.50% | -5.54% | -17.03% | -13.71% | -38.75% | -53.78% | -13.98% | 6.62B | |
| -2.60% | -8.32% | -4.53% | +22.61% | -0.06% | -5.60% | +158.28% | +144.05% | +874.18% | 5.76B | |
| +1.92% | +3.46% | +3.54% | +17.47% | +32.29% | +17.79% | +67.66% | -2.91% | +233.92% | 3.36B | |
| +3.85% | -15.69% | +3.86% | +39.25% | -31.97% | -22.54% | +2,364.62% | -67.14% | - | 2.54B | |
| +6.54% | -1.66% | +19.20% | +51.63% | +66.33% | +148.54% | +60.99% | -58.26% | +134.81% | 2.36B | |
| +17.77% | +2.56% | +18.47% | +45.12% | +46.67% | +35.30% | +45.12% | -0.43% | +20.56% | 2.32B | |
| +1.10% | +8.21% | -6.25% | +21.05% | +3.63% | +0.72% | -52.89% | -70.65% | - | 1.98B | |
| -1.33% | +12.32% | +0.68% | +7.22% | +31.17% | +33.10% | -11.57% | -29.62% | -34.83% | 1.92B | |
| -2.81% | +6.13% | +1.47% | +17.91% | +43.87% | +45.41% | +235.05% | +163.48% | - | 1.69B | |
| -3.53% | +1.23% | +10.81% | +10.07% | +30.16% | +10.81% | +1.23% | -56.27% | -85.21% | 1.27B | |
| +1.15% | -1.07% | -1.72% | +13.94% | +6.36% | +3.07% | +35.43% | +13.29% | -30.43% | 1.26B | |
| +5.21% | +48.26% | +27.90% | +58.51% | +53.61% | +36.27% | -8.27% | -56.41% | - | 1.17B | |
| -1.27% | +4.97% | +0.17% | +1.48% | +27.01% | +41.37% | +201.36% | +34.55% | +178.42% | 953M | |
| +0.68% | +0.13% | +2.06% | +2.49% | -3.89% | -0.40% | +32.41% | -15.87% | +40.90% | 869M | |
| -2.39% | +12.52% | +3.13% | +31.78% | +28.22% | +29.19% | -18.43% | -45.22% | - | 721M | |
| +7.60% | +66.02% | +62.87% | +66.63% | +53.41% | +48.27% | +27.13% | -32.99% | -16.79% | 627M | |
| -2.41% | +31.14% | +23.24% | +58.35% | +27.12% | -2.16% | +29.23% | - | - | 615M | |
| Average | +2.36% | +7.55% | +11.00% | +30.79% | +25.92% | +28.32% | +209.02% | +6.45% | +398.97% | 5.86B | |
| Weighted average by Cap. | +3.01% | +6.17% | +10.88% | +37.65% | +47.07% | +79.21% | +457.73% | +120.68% | +2,040.42% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions
